Results 131 to 140 of about 9,079 (152)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

Journal of Infection, 2006
David Denning, , Priscilla Flynn
exaly  

In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates

Antimicrobial Agents and Chemotherapy, 2017
Pilar Escribano, Emilio Bouza, Jesus Vicente Guinea Ortega   +2 more
exaly  

Micafungin

Reactions Weekly, 2013
  +4 more sources

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Lancet, The, 2007
CARLOS Barrios, Ploenchan Chetchotisakd, Oliver A Cornely   +2 more
exaly  

Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers

Journal of Clinical Pharmacology, 2005
Ihor Bekersky
exaly  

Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

Journal of Clinical Pharmacology, 2005
William Smith, Ihor Bekersky, Helen E Smith   +2 more
exaly  

MICAFUNGIN

Reactions Weekly, 2010
openaire   +2 more sources

Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum binding

Biopharmaceutics and Drug Disposition, 2011
Patrick Augustijns, Pieter Annaert
exaly  

Population pharmacokinetics of micafungin in adult patients

Diagnostic Microbiology and Infectious Disease, 2008
Tawanda Gumbo, George Drusano, Donald N Buell   +2 more
exaly  

Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers

Journal of Clinical Pharmacology, 2005
Ihor Bekersky
exaly